Latest News about HOOK
Recent news which mentions HOOK
70 Biggest Movers From Friday
February 22, 2022
From Benzinga
A few setups for the upcoming days
February 20, 2022
From AC Investor Blog
12 Health Care Stocks Moving In Friday's After-Market Session
February 18, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 18, 2022
From Benzinga
25 Stocks Moving in Thursday's Pre-Market Session
February 17, 2022
From Benzinga
56 Biggest Movers From Yesterday
February 17, 2022
From Benzinga
Mid-Afternoon Market Update: US Stocks Pare Losses; S&P 500 Turns Higher
February 16, 2022
From Benzinga
Mid-Day Market Update: Crude Oil Rises 2%; EIA Reports Unexpected Rise In Crude Inventories
February 16, 2022
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 16, 2022
From Benzinga
Hookipa Pharma Stock Surges On HIV Pact With Gilead
February 16, 2022
From Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
From Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
February 16, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 02, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 12, 2022
From Benzinga
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 12, 2021
November 12, 2021
From Benzinga
What 5 Analyst Ratings Have To Say About HOOKIPA Pharma
November 11, 2021
Tickers
HOOK
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 10, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial
September 15, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.